Keyphrases
Colorectal Cancer Survivorship
100%
Surveillance Guidelines
100%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Post-treatment Surveillance
100%
Survivorship Care Plan
100%
Cytoreductive Surgery
83%
Postoperative Morbidity
66%
Confidence Interval
50%
Odds Ratio
50%
Operative Time
50%
Cancer Diagnosis
40%
Cancer Treatment
40%
Postoperative Mortality
33%
Clinical Outcomes
33%
Length of Stay
33%
Colonoscopy Surveillance
20%
Randomized Controlled Trial
20%
Community Cancer Center
20%
National Comprehensive Cancer Network Guidelines
20%
Plan Content
20%
Promotion Recommendation
20%
Predisposing Conditions
20%
Colorectal Cancer
20%
Cancer Incidence
20%
Genetic Counseling
20%
Cancer-specific
20%
Imaging Surveillance
20%
Treatment Side Effects
20%
Chemotherapy
20%
Health Promotion
20%
Cancer Center
20%
Pertinent Information
20%
American Society of Clinical Oncology
20%
Carcinoembryonic Antigen
20%
Colonoscopy
20%
Academic Cancer Center
20%
American Cancer Society
20%
Treatment Surgery
20%
Risk Factors
16%
Favorable Outcome
16%
Inclusion Criteria
16%
Primary Tumor Site
16%
Peritoneum
16%
Colon
16%
Hematocrit
16%
Temporal Trends
16%
Postoperative Complications
16%
Identify Risk
16%
Peritoneal Carcinomatosis
16%
Logistic Regression Analysis
16%
Medicine and Dentistry
Hyperthermic Intraperitoneal Chemotherapy
100%
Colorectal Cancer
100%
Malignant Neoplasm
100%
Survivorship in Cancer Care
100%
Cytoreductive Surgery
100%
Odds Ratio
50%
Operation Duration
50%
Cancer Therapy
33%
Colonoscopy
33%
Cancer Diagnosis
33%
Vermiform Appendix
16%
Serum Albumin
16%
Side Effect
16%
Hematocrit
16%
Postoperative Complication
16%
Surgeon
16%
Randomized Controlled Trial
16%
Peritoneum
16%
Genetic Counseling
16%
Clinical Oncology
16%
Carcinomatous Peritonitis
16%
Primary Tumor
16%
Carcinoembryonic Antigen
16%
Patient Selection
16%
Quality Improvement
16%
Colon
16%
Logistic Regression Analysis
16%
Health Promotion
16%
Nursing and Health Professions
Cytoreductive Surgery
100%
Hyperthermic Intraperitoneal Chemotherapy
100%
Operation Duration
50%
Confidence Interval
50%
Odds Ratio
50%
Clinical Outcome
33%
Length of Stay
33%
Serum Albumin
16%
Logistic Regression Analysis
16%
Patient Selection
16%
Hematocrit
16%
Total Quality Management
16%
Postoperative Complication
16%
Primary Tumor
16%
Carcinomatous Peritonitis
16%
